These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 19853699)

  • 1. Does intensity of rate control influence outcome in persistent atrial fibrillation? Data of the RACE study.
    Groenveld HF; Crijns HJ; Rienstra M; Van den Berg MP; Van Veldhuisen DJ; Van Gelder IC;
    Am Heart J; 2009 Nov; 158(5):785-91. PubMed ID: 19853699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gender-related differences in rhythm control treatment in persistent atrial fibrillation: data of the Rate Control Versus Electrical Cardioversion (RACE) study.
    Rienstra M; Van Veldhuisen DJ; Hagens VE; Ranchor AV; Veeger NJ; Crijns HJ; Van Gelder IC;
    J Am Coll Cardiol; 2005 Oct; 46(7):1298-306. PubMed ID: 16198847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mending the rhythm does not improve prognosis in patients with persistent atrial fibrillation: a subanalysis of the RACE study.
    Rienstra M; Van Gelder IC; Hagens VE; Veeger NJ; Van Veldhuisen DJ; Crijns HJ
    Eur Heart J; 2006 Feb; 27(3):357-64. PubMed ID: 16275661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation.
    Van Gelder IC; Hagens VE; Bosker HA; Kingma JH; Kamp O; Kingma T; Said SA; Darmanata JI; Timmermans AJ; Tijssen JG; Crijns HJ;
    N Engl J Med; 2002 Dec; 347(23):1834-40. PubMed ID: 12466507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RAte Control Efficacy in permanent atrial fibrillation: a comparison between lenient versus strict rate control in patients with and without heart failure. Background, aims, and design of RACE II.
    Van Gelder IC; Van Veldhuisen DJ; Crijns HJ; Tuininga YS; Tijssen JG; Alings AM; Bosker HA; Cornel JH; Kamp O; Veeger NJ; Volbeda M; Rienstra M; Ranchor AV; TenVergert EM; Van den Berg MP
    Am Heart J; 2006 Sep; 152(3):420-6. PubMed ID: 16923407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Verapamil versus digoxin and acute versus routine serial cardioversion for the improvement of rhythm control for persistent atrial fibrillation.
    Hemels ME; Van Noord T; Crijns HJ; Van Veldhuisen DJ; Veeger NJ; Bosker HA; Wiesfeld AC; Van den Berg MP; Ranchor AV; Van Gelder IC
    J Am Coll Cardiol; 2006 Sep; 48(5):1001-9. PubMed ID: 16949494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improvement in exercise performance after successful cardioversion in patients with persistent atrial fibrillation and symptoms of heart failure.
    Wozakowska-Kapłon B; Opolski G
    Kardiol Pol; 2003 Sep; 59(9):213-23. PubMed ID: 14618198
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomised, controlled study of rate versus rhythm control in patients with chronic atrial fibrillation and heart failure: (CAFE-II Study).
    Shelton RJ; Clark AL; Goode K; Rigby AS; Houghton T; Kaye GC; Cleland JG
    Heart; 2009 Jun; 95(11):924-30. PubMed ID: 19282313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rate-control versus conversion strategy in postoperative atrial fibrillation: a prospective, randomized pilot study.
    Lee JK; Klein GJ; Krahn AD; Yee R; Zarnke K; Simpson C; Skanes A; Spindler B
    Am Heart J; 2000 Dec; 140(6):871-7. PubMed ID: 11099990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of rate control on quality of life in patients with permanent atrial fibrillation: data from the RACE II (Rate Control Efficacy in Permanent Atrial Fibrillation II) study.
    Groenveld HF; Crijns HJ; Van den Berg MP; Van Sonderen E; Alings AM; Tijssen JG; Hillege HL; Tuininga YS; Van Veldhuisen DJ; Ranchor AV; Van Gelder IC;
    J Am Coll Cardiol; 2011 Oct; 58(17):1795-803. PubMed ID: 21996393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does intensity of rate-control influence outcome in atrial fibrillation? An analysis of pooled data from the RACE and AFFIRM studies.
    Van Gelder IC; Wyse DG; Chandler ML; Cooper HA; Olshansky B; Hagens VE; Crijns HJ;
    Europace; 2006 Nov; 8(11):935-42. PubMed ID: 16973686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term outcome of the atrioventricular node ablation and pacemaker implantation for symptomatic refractory atrial fibrillation.
    Tan ES; Rienstra M; Wiesfeld AC; Schoonderwoerd BA; Hobbel HH; Van Gelder IC
    Europace; 2008 Apr; 10(4):412-8. PubMed ID: 18272509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relation between achieved heart rate and outcomes in patients with atrial fibrillation (from the Atrial Fibrillation Follow-up Investigation of Rhythm Management [AFFIRM] Study).
    Cooper HA; Bloomfield DA; Bush DE; Katcher MS; Rawlins M; Sacco JD; Chandler M;
    Am J Cardiol; 2004 May; 93(10):1247-53. PubMed ID: 15135698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Control of rate versus rhythm in rheumatic atrial fibrillation: a randomized study.
    Vora A; Karnad D; Goyal V; Naik A; Gupta A; Lokhandwala Y; Kulkarni H; Singh B
    Indian Heart J; 2004; 56(2):110-6. PubMed ID: 15377131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AFFIRM and RACE trials: implications for the management of atrial fibrillation.
    Blackshear JL; Safford RE; ;
    Card Electrophysiol Rev; 2003 Dec; 7(4):366-9. PubMed ID: 15071255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional status in rate- versus rhythm-control strategies for atrial fibrillation: results of the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) Functional Status Substudy.
    Chung MK; Shemanski L; Sherman DG; Greene HL; Hogan DB; Kellen JC; Kim SG; Martin LW; Rosenberg Y; Wyse DG;
    J Am Coll Cardiol; 2005 Nov; 46(10):1891-9. PubMed ID: 16286177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rate control is more cost-effective than rhythm control for patients with persistent atrial fibrillation--results from the RAte Control versus Electrical cardioversion (RACE) study.
    Hagens VE; Vermeulen KM; TenVergert EM; Van Veldhuisen DJ; Bosker HA; Kamp O; Kingma JH; Tijssen JG; Crijns HJ; Van Gelder IC;
    Eur Heart J; 2004 Sep; 25(17):1542-9. PubMed ID: 15342174
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lenient versus strict rate control in patients with atrial fibrillation.
    Van Gelder IC; Groenveld HF; Crijns HJ; Tuininga YS; Tijssen JG; Alings AM; Hillege HL; Bergsma-Kadijk JA; Cornel JH; Kamp O; Tukkie R; Bosker HA; Van Veldhuisen DJ; Van den Berg MP;
    N Engl J Med; 2010 Apr; 362(15):1363-73. PubMed ID: 20231232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dronedarone for the control of ventricular rate in permanent atrial fibrillation: the Efficacy and safety of dRonedArone for the cOntrol of ventricular rate during atrial fibrillation (ERATO) study.
    Davy JM; Herold M; Hoglund C; Timmermans A; Alings A; Radzik D; Van Kempen L;
    Am Heart J; 2008 Sep; 156(3):527.e1-9. PubMed ID: 18760136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of sinus rhythm restoration and maintenance on left ventricular function and exercise tolerance in patients with persistent atrial fibrillation.
    Kosior DA; Stawicki S; Wozakowska-Kapłon B; Szulc M; Opolski G; Rabczenko D
    Kardiol Pol; 2005 Jul; 63(7):36-47; discussion 48-9. PubMed ID: 16136427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.